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ABSTRACT 
Telomere repeat binding factor 2 (TRF2) is a component of the shelterin complex that is known 
to bind and protect telomeric DNA, yet the detection of TRF2 in extra-telomeric regions of 
chromosomes suggests other roles for TRF2 besides telomere protection. Here, we demonstrate 
that TRF2 plays a critical role in antagonizing the repressive function of Neuron-Restrictive 
Silencer Factor (NSRF), also known as Repressor Element-1 Silencing Transcription Factor 
(REST), during the neural differentiation of human embryonic stem cells (hESCs) by enhancing 
the expression of a truncated REST splice isoform we term human REST4 (hREST4) due to its 
similarity to rodent REST4. We show that TRF2 is specifically upregulated during hESC neural 
differentiation concordantly with an increase in the expression of hREST4 and that both proteins 
are highly expressed in NPCs. Overexpression of TRF2 in hESCs increases hREST4 levels and 
induces their neural differentiation, whereas TRF2 knockdown in hESCs and NPCs reduces 
hREST4 expression, hindering their ability to differentiate to the neural lineage. Concurrently, 
we show that TRF2 directly interacts with the C-terminal of hREST4 through its TRF2 core 
binding motif [F/Y]xL, protecting hREST4 from ubiquitin mediated proteasomal degradation 
and consequently furthering neural induction. Thus, the TRF2-mediated counterbalance between 
hREST4 and REST is vital for both the generation and maintenance of NPCs, suggesting an 
important role for TRF2 in both neurogenesis and function of the central nervous system.  
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INTRODUCTION 
In developing neural regenerative therapies, it is imperative to understand the molecular 
mechanisms regulating neurogenesis in the central nervous system (CNS), particularly those 
involved in the production and maintenance of human neural progenitors cells (NPCs) as these 
cells can potentially replenish the damaged neural cells that contribute to neurodegenerative 
diseases. Human embryonic stem cells (hESCs) provide a powerful platform for such studies, as 
they can be expanded indefinitely while retaining the ability to differentiate into all neural 
lineages. Moreover, the in vitro neural differentiation of hESCs recapitulates the normal 
development of the CNS in vivo and involves major transcriptomic changes regulated by a 
plethora of different factors, including chromatin regulators, transcription modulators, signaling 
mediators and miRNAs [1, 2]. Amongst them, Repressor Element-1 Silencing Transcription 
factor (REST), a master transcriptional repressor, has been shown to be a key player in this 
process [3, 4], although the contribution of various REST isoforms to neural induction is still 
unclear. Furthermore, since most of these studies were conducted in mouse ESCs (mESCs), the 
function of REST and its isoforms during hESC neural differentiation remains unknown. 
TRF2 is a component of the shelterin complex that binds to telomeric DNA, protecting the 
chromosome ends and hence maintains genome stability [5]. However, recent evidence 
demonstrating the ability of TRF2 to bind to non-telomeric regions of the chromosomes [6-8] 
and to function as a protein hub [9-12] suggests that it may have alternative functions 
independent of telomere maintenance. Despite the importance of TRF2, its expression and 
involvement in development and tissue homeostasis remain largely unknown. This is because the 
majority of studies were performed in either tumor cell lines or primary/immortalized fibroblasts 
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which may not be adequate representatives of normal developmental tissues. Furthermore, TRF2 
knockout mice exhibit embryonic lethality, restricting interrogation of TRF2 functions during 
development [13].  
Here we investigated the role of TRF2 in hESCs and their differentiated progenies. Given the 
abundance of TRF2 in the human brain [14], we focused our studies particularly on the neural 
differentiation and uncovered strikingly dynamic changes in TRF2 expression during this 
process. Using gain and loss of function approaches, we have identified a critical role for TRF2 
in promoting neural differentiation of hESCs and maintaining NPC neuropotency. Furthermore, 
we have deciphered the molecular mechanisms responsible for this effect, whereby TRF2 
alleviates the repression of REST on neural genes by enhancing the expression of hREST4, a 
splice variant of human REST, similar in structure to rodent REST4 [15, 16], which counteracts 
the repressive action of REST on neural genes. 
 
MATERIALS AND METHODS 
Cell culture and differentiation  
Human embryonic stem cell lines H1 and H7 were obtained from WiCell (Madison, VA) and 
routinely propagated under feeder-free conditions with mouse embryonic fibroblast conditioned 
media (MEF-CM) as described previously [17]. Neural differentiation of hESCs and culture and 
differentiation of NPCs were performed with our established protocols [2, 18, 19]. Fibroblast 
differentiation of hESCs was induced by replacing hESC culture medium with Dulbecco's 
Modified Eagle's Medium (DMEM) containing 10% fetal calf serum (FCS) (Sigma-Aldrich) and 
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1% L-glutamine (Life Technologies) for over three weeks. Differentiation of hESCs to 
hepatocyte progenitors and embryoid bodies (EB) formation were performed as previously 
described [17, 20, 21]. 
 
Expression plasmids  
TRF2-overexpressing lentivector was derived from pLVTHM [22] with TRF2 cDNA isolated 
from pLPC-TRF2 [23]. Both were obtained from Addgene. Briefly, the stop codon of puromycin 
resistant cDNA (PURO) in pPUR (Clontech) was mutated by site-directed mutagenesis and a 2A 
foot and mouth disease virus sequence [24] was inserted downstream of the PURO. The PURO-
2A fragment was then fused with TRF2 cDNA and inserted into pLVTHM. TRF2-knockdown 
(TRF2-sh) vector was generated by replacing scrambled shRNA in pLVTHM with a duplex 
oligonucleotide targeting TRF2 mRNA 5′-CGCGCAGGAGCATGGTTCCTAATAATACT-
GCAGTATTATTAGGAACCATGCTCCTGTTTTT-3′ and 5′-GCAAAAACAGGAGCAT-
GGTTCCTAATAATACTGCAGTATTATTAGGAACCATGCTCCTG-3′. Both hREST4 and 
hREST4m expression vectors were generated from pLCMV-Neo-Myc-REST, a kind gift from 
Dr S. Bao [25], by replacing REST C-terminal sequence with an oligonucleotide duplex 
containing either hREST4 exon N coding sequence or a stop codon. hREST4 lentivector was 
generated by replacing TRF2 in pLVTHM-PURO-2A-TRF2 with hREST4 cDNA. pCS2-HA-
TRF2 was generated by cloning TRF2 cDNA into pCS2-HA. HA and Myc epitopes were added 
to the N-termini of TRF2 or REST/hREST4 proteins, respectively. All constructs were verified 
by sequencing.  
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Lentiviral production and transduction  
Lentiviruses were produced by transient transfection of HEK293T cells with a lentivector as well 
as pCMV∆8.91 helper and pVSV-G envelope plasmids using standard protocols [22] and 
immediately stored at -80ºC until use. 24 hours prior to infection, hESCs were split with accutase 
and seeded into Matrigel-coated plates in hESC medium containing 10 µM ROCK inhibitor Y-
27632 (Reagents Direct) [26]. Cells were selected for puromycin resistance 72 hours post-
infection. NPCs were infected similarly to hESCs but under NPC culture conditions.  
 
Immunoblotting (IB), immunostaining and flow cytometry 
Immunoblotting and immunostaining were performed as previously described [18] with minor 
modification. For immunoblotting, cells were lysed in cold radio immunoprecipitation assay 
(RIPA) buffer (150 mM NaCl, 50 mM Tris-HCl pH 8.0, 12 mM sodium deoxycholate, 0.1% 
sodium dodecyl sulphate (SDS), 1% NP-40) containing protease inhibitor cocktail and 0.2 mM 
phenylmethanesulfonylfluoride (PMSF) (Sigma-Aldrich).  20 µg proteins were resolved in 7% 
SDS-polyacrylamide gel. Quantification of protein bands was carried out using Quantity One 
software (Bio-Rad). Statistical analyses were performed by Student’s t-test from data of three 
independent experiments. For immunostaining, hESCs and NPCs were seeded onto Matrigel-
coated Nunc Thermanox (Thermo Scientific) and poly-L-lysine/laminin-coated glass coverslips 
respectively and were stained with antibodies post-fixation. Primary antibodies used are listed in 
Table S1. Flow cytometry was performed as previously described [18]. 
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Immunoprecipitation (IP) 
Cells were lysed in ice-cold lysis buffer (20 mM HEPES PH7.4, 10 mM KCl, 100 mM NaCl2, 1 
mM EDTA, 0.1 mM EGTA, 0.1% triton X-100, 0.5% NP-40) containing protease inhibitor 
cocktail and 0.2 mM PMSF. 1 mg of extracts was incubated with 2-3 µg antibodies at 4°C for 1-
3 h with rotation. Immunocomplexes were captured at 4°C with either 20 µl Protein A/G Plus 
agarose beads (Santa Cruz) for 1 h or 50 µl Protein G Dynabeads (Life Technologies) for 3 
hours. Immunoprecipitates were eluted with 2X Laemmli buffer and boiled for 10 min, then 
analyzed by immunoblotting.  
 
hREST4 ubiquitination assay  
Cells co-transfected with pLCMV-Neo-Myc-hREST4 and HA-Ubiquitin plasmids were treated 
with 20 µM MG132 (Merck) for 5 h and then lysed in cold lysis buffer (50 mM Tris-HCl, pH 
7.4, 150 mM NaCl, 5 mM EDTA, 1% NP40) containing protease inhibitor cocktail, 0.2 mM 
PMSF and 1 µM ubiquitin aldehyde (Boston Biochem)). 1 mg of lysate was subjected to 
immunoprecipitation followed by immunoblotting as above. 
 
Telomere fluorescent in situ hybridization (FISH) and immuno-FISH  
Metaphase spreads preparation: cells were harvested in 0.8% sodium citrate after treatment with 
0.5 µg/ml colcemid (Life Technologies) at 37°C for 4 hours and incubated at 37°C for 15 
minutes. Cells were then fixed in 3:1 methanol-acetic acid and dropped onto clean glass slides. 
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FISH was performed using Telomere PNA FISH kit (DAKO) following manufacturer’s 
instructions. For immuno-FISH, cells were first subjected to immunostaining as above, which 
were followed by fixation in 3.7% formaldehyde and dehydration in cold ethanol series. The 
cells were then incubated with PNA probe 5 minutes at 85°C followed by overnight at 37°C, 
Wash cells in 70% formamide and 2X SSC for 5 minutes each. Finally, cells were dried and 
mounted with VECTASHIELD (DAKO) solution containing 4,5-diamidino-2-phelylindole 
(DAPI). 
 
Telomere length assay  
Telomere lengths were measured by telomere restriction fragment (TRF) Southern blot using a 
TeloTAGGG telomere length assay kit (Roche).  
 
Quantitative RT-PCR  
RNA isolation and cDNA synthesis were performed as described previously [18].  PCR reactions 
were carried out in an Opticon thermal cycler (Bio-Rad) using the primers listed in Table S2. 
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RESULTS 
TRF2 protein is upregulated during the neural differentiation of hESCs and maintained at 
high levels in neural progenitors. 
In order to explore the role of TRF1 and TRF2 in hESCs and their neural progenies, we first 
examined their mRNA expression in both H1 and H7 hESCs together with hESC-derived NPCs.  
TRF1 mRNA was highly expressed in hESCs but was radically reduced following neural 
differentiation and maintained at low levels throughout the NPC culture, whereas the expression 
of TRF2 transcripts did not exhibit an obvious pattern of change (Fig. 1A).  These results are 
consistent with our previous genome-wide RNA sequencing results [19] and published data [27, 
28]. However, in contrast to the mRNA expression, TRF1 protein did not show a considerable 
reduction upon neural differentiation. More surprisingly, in both H1 and H7 hESC lines, TRF2 
protein levels were low in hESCs, but dramatically increased following neural differentiation and 
were maintained at these elevated levels throughout extended culture (Fig. 1B-C, Fig. S1A). The 
discrepancy between mRNA and protein levels of TRF1 and TRF2 indicate that both proteins are 
regulated at the post-transcriptional level, in line with previous findings [29, 30]. Analysis of 
additional protein samples from independent differentiation experiments further confirmed the 
significant upregulation of TRF2 protein in H1 and H7 upon neural differentiation (Fig. 1B, right 
panels). Furthermore, although TRF2 proteins were predominantly located in cell nuclei of NPCs 
as they are in hESCs (Fig. 1C-D), they were not solely restricted to the telomeres (Fig. 1E). 
Interestingly, TRF2 protein was found at lower levels in mESCs than in hESCs and did not 
exhibit any upregulation upon neural differentiation (Fig. S1B). Therefore, TRF2 levels are 
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considerably lower in mouse NPCs than in human NPCs, highlighting yet another difference 
between human and mouse biology.  
Overall our results indicate that whilst the expression of TRF1 is relatively similar between 
hESC and NPCs at various stages of the differentiation, there is contrastingly a considerable 
upregulation in the expression of TRF2 protein upon neural differentiation. Additionally, TRF2 
is abundantly distributed throughout the nuclei of NPCs rather than being confined solely to the 
telomeres, which suggests an extra-telomeric role for TRF2 during neural differentiation.  
 
Upregulation of TRF2 is specific to human neural progenitors  
Since TRF2 exhibited a more distinctive change during the neural differentiation of hESCs, we 
focused our subsequent studies on TRF2. We asked whether TRF2 upregulation is a general 
phenomenon in hESC differentiation to all lineages or is specifically restricted to NPCs. To 
address this, we differentiated hESCs via embryoid body formation to the three germ layers. 
Following differentiation, TRF2 was mainly detected in neural progenitors that were positive for 
Sox2 but negative for Oct4 and HNF4α (Fig. S2A). Similarly, TRF2 levels were found to be low 
in several non-neural cell lines (Fig. S2B). To further corroborate these findings, we 
differentiated hESCs specifically to neural, hepatic or fibroblast lineages in which majority of the 
cells displayed their lineage-specific morphology and corresponding gene expression profiles 
(Fig. 2A-B). TRF2 was upregulated only in NPCs, but not in hepatocyte progenitors or 
fibroblasts (Fig. 2C). Furthermore, when NPCs were further differentiated into post-mitotic 
neurons or glia, TRF2 levels were again reduced (Fig. 2D-E). Our data demonstrate that TRF2 
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expression is dynamically regulated during neural differentiation and neuron/glia formation with 
higher levels being restricted to NPCs. 
 
Differential expression of TRF2 neither correlates with telomere length nor telomerase 
expression 
Since the protective and regulatory role of TRF2 with regards to telomeres has been well 
characterized [31, 32], we investigated whether the dramatic changes of TRF2 expression during 
hESC neural differentiation correlated with changes in either telomere length or telomerase 
expression. In hESCs, telomeres are long and stable due to high telomerase expression. Upon 
neural differentiation, expression of telomerase was considerably downregulated and telomeres 
shortened with subsequent cell proliferation. Following extended culture of NPCs, telomerase 
was reactivated in latter passages, which led to subsequent lengthening of the telomeres (Fig. 
3A-B). These dynamic changes of telomere length were notably different to that of TRF2 
expression (Fig. 3B vs.1B). H1 hESCs had similar telomere lengths to the p4 NPCs (Fig. 3B), 
but they expressed much lower levels of TRF2 (Fig. 1B), whereas although telomeres were 
significantly longer in p4 than p27 NPCs, both passages expressed similar levels of TRF2. 
Additionally, in-situ immunostaining of chromosomal spreads also showed a lack of correlation 
between telomere length and TRF2 expression (Fig. 3C). Overall, these studies therefore 
demonstrate the independence of TRF2 expression from both telomere length and telomerase 
expression. 
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Ectopic expression of TRF2 in hESCs promotes neural differentiation 
Since TRF2 is significantly upregulated during neural differentiation of hESCs, we speculated 
that it might also play a critical role in this process. We applied gain and loss of function 
approaches to address this, whereby TRF2 was ectopically expressed in H1 hESCs by lentiviral 
transduction in the first instance (Fig. 4A). Following selection, several colonies in the TRF2-
overexpressing (TRF2-ov) plates emerged with neural rosette-like structures (Fig. 4B), and this 
differentiation became more evident upon continuous culture with the appearance of bipolar 
neural progenitors (Fig. S3A). In contrast, no such phenotype was observed in the controls. 
These morphological changes were reproducible in repeated experiments. Gene expression 
analysis revealed a downregulation of pluripotent markers Oct4 and Nanog, coupled with an 
upregulation of neural markers Sox1, Mash1 and Snap25 in TRF2-ov cells (Fig. 4C-D). Flow 
cytometry and immunostaining also showed that a proportion of TRF2-ov hESCs expressed 
neural lineage markers despite being cultured under hESC culture conditions (Fig. 4E-G). 
Furthermore, when TRF2-ov hESCs were transferred into neural differentiation conditions, they 
differentiated faster when compared to control cells. Although a high proportion of control cells 
still expressed high levels of Oct4 by day 12 of the differentiation, very few TRF2-ov cells were 
positive for Oct4 and the majority of them expressed the neural progenitor marker Nestin (Fig. 
S3B-C). Given that the neural differentiation emerged before passage 4 in TRF2-ov hESCs, and 
that telomere attrition was detected after passage 5 (Fig. 4H), it is unlikely that this phenotype is 
a consequence of telomere shortening. Furthermore, we did not detect any increase of γH2AX in 
TRF2-ov hESCs (Fig. 4D), indicating that the differentiation is unlikely to be attributed to DNA 
damage. These results therefore demonstrate that TRF2 plays a positive role in promoting neural 
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differentiation of hESCs, which is independent from its role in regulating telomere length and 
protection of the chromosomes. 
 
TRF2 knockdown hinders neural differentiation of hESCs and neural competence of NPCs 
Complementary to the overexpression experiments, we also examined the effect of TRF2 
deficiency in neural differentiation by knocking down TRF2 with shRNA (TRF2-sh) in hESCs 
and hESC-derived NPCs (Fig. 5A-B). Both TRF2-sh hESCs and NPCs did not display clear 
morphological changes under normal growth conditions (Fig. 5C and 5I, upper panels). The 
TRF2-sh hESCs exhibited similar levels of pluripotent markers, Oct4, Nanog and Sox2 (Fig. 
5D). However, when differentiated via EB, TRF2-sh hESCs generated much less Tuj1 positive 
neurons than the controls, even though no clear difference was observed in the staining of 
endoderm markers, HNF4α and AFP (Fig 5E). Furthermore, direct neural differentiation of 
TRF2-sh hESCs revealed a reduction in the generation of neural progenitors (Fig. 5C, lower 
panel; Fig. 5F), which led to decreased number of neurons upon growth factor withdrawal (Fig. 
S4A). These results indicate that TRF2 is important for the neural differentiation of hESCs. 
In line with our observation in the neural differentiation of TRF2-sh hESCs, knockdown of 
TRF2 in NPCs also revealed clear reduction in the expression of neural progenitor and neuronal 
markers, Sox2, Mash1 and Snap25 (Fig. 5G-H), despite no clear morphological changes (Fig. 5I, 
upper panel). There was no apparent cell death in these cells but cell proliferation was slightly 
reduced (Fig. S4B-D). Upon further differentiation to neurons and glia, control cells developed 
long and multiple processes of interconnecting outgrowths, whereas the TRF2-sh cells appeared 
flatter, with fewer outgrowths (Fig. 5I, lower panel). Correspondingly, TRF2-sh cells displayed a 
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clear reduction in Tuj1 and GFAP staining (Fig. 5J). Interestingly, knockdown of TRF2 in both 
hESCs and NPCs did not affect telomere length (Fig. S4E-F) and no obvious chromosome end 
joining was observed (Fig. S4G). These results demonstrate that a deficiency of TRF2 decreases 
neural gene expression and diminishes the capability of NPCs to further differentiate into 
neurons and glia without any evident effect on the telomeres. Therefore, TRF2 appears to play an 
important role not only in the differentiation but also in the maintenance of NPCs.  
 
TRF2 expression affects hREST4 but not REST expression in hESCs and NPCs 
In line with the observed impact upon neural differentiation, TRF2 has also been previously 
reported to inhibit neuronal differentiation of human embryonic carcinoma NTera2 cells by 
interacting with REST and stabilizing its expression [33]. Given the importance of REST to 
neural differentiation, we examined REST expression in hESCs and their neural progenies to see 
whether this correlates with TRF2 expression as a potential mechanism to explain our 
observations. Surprisingly, we did not detect any significant differences in REST expression 
between hESCs and their differentiated NPCs even though TRF2 was clearly upregulated in 
NPCs (Fig. 6A-B). Accordingly, there is no clear correlation between TRF2 and REST 
expression during hESC neural differentiation. This is further supported by the fact that REST 
levels showed no change in TRF2-ov hESCs or HEK293T cells and in TRF2-knockdown NPCs 
(Fig. 6D & 6E, Fig. S5A). Of note, expression of TRF2 and REST was shown to be considerably 
higher in NTera2 cells than in hESCs, whilst the level of TRF2 in NTera2 cells was similar to 
that of hESC-derived NPCs (Fig. S5B). High levels of TRF2 in NTera2 cells, together with the 
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fact that NTera2 cells are more easily differentiated into neural lineages via retinoic acid 
treatment than hESCs, further support our notion of TRF2 promoting neural differentiation.   
Interestingly, the relatively stable REST expression we have observed during neural 
differentiation of hESCs is different from that reported during mESC neural differentiation, 
which showed a downregulation of REST. This reduction was thought to alleviate REST 
repression on neural genes, hence promoting neural differentiation [34]. This has raised the 
question as to how REST-mediated repression on neural genes is mitigated during hESC neural 
differentiation. We noticed that the REST antibody, raised against the N-terminus of human 
REST, consistently detected a ~40-kDa band in NPCs, which is lower in molecular weight than 
that of REST (Fig. 6A & 6F). Although the antibody also detected a couple of other bands, these 
did not appear when using other batches of the antibody, and were therefore considered to be 
non-specific (Fig. 6A & 6F; Fig. S6C). Interestingly, this ~40kDa protein exhibited a pattern of 
upregulation similar to that of TRF2 during the neural differentiation (Fig. 6B) and is of a similar 
molecular weight to the predicated size of REST-N62, a human REST isoform that is 
orthologous to the rodent neural-specific REST isoform REST4 [15, 16, 35]. Correspondingly, 
immunoblotting with the REST antibody on HEK293T cell extracts overexpressing REST and 
REST-N62 revealed the presence of only two bands of 160-200 and ~40 kDa, respectively (Fig. 
S5C). Human REST-N62 is generated by the alternative splicing of a neural-specific exon (exon 
N) located between exon IV and V to produce a 62 nucleotide insertion in the REST mRNA, 
containing an in-frame stop codon that causes premature translation termination and synthesis of 
truncated REST protein (Fig. 6C) [16]. Although no function has been ascribed to REST-N62, 
the rodent protein orthologous REST4 has been shown to counteract the repressive role of REST 
in the regulation of its target genes, particularly during neurogenesis [16, 35-38]. Whilst the 
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protein sequence encoded by exon N differs between REST-N62 and rodent REST4 (Fig. S5D), 
both retain the REST N-terminal domain and 5 of the 9 zinc-finger DNA binding domains, but 
lack the C-terminal repression domain (Fig. 6C). Hence, we have appropriately termed this 
REST-N62 variant as human REST4 (hREST4) and given the similarity in protein structure to 
the rodent REST4, posit its involvement in regulating neural differentiation through a similar 
mechanism.  
To validate this hypothesis, hREST4 was ectopically expressed (hREST4-ov) in hESCs. These 
cells exhibited compromised self-renewal and increased cell differentiation, particularly towards 
the neural lineage even under hESC culture conditions (Fig. S6A-D). In addition, when subjected 
to neural differentiation, hREST4-ov hESCs, like TRF2-ov hESCs, showed a quicker and more 
efficient conversion (Fig. S6A & S6E). These results indicate that hREST4 undermines the 
pluripotency of hESCs, possibly through affecting the repression of neural genes by REST. In 
exploring this relationship between TRF2 and hREST4 further, we showed that overexpressing 
TRF2 increased hREST4 protein levels in hESCs whereas knockdown of TRF2 reduced hREST4 
in NPCs (Fig. 6D-E, Fig. S5E). Furthermore, we were able to rescue the defects in neural gene 
expression and formation of neurons and astrocytes observed in TRF2-sh NPCs through hREST4 
overexpression without altering TRF2 levels (Fig. 6F-H). Overall, our data suggest that TRF2 
may act upstream of hREST4 to enhance its expression, subsequently affecting the neural 
differentiation of hESCs and the preservation of NPC neuropotency. 
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TRF2 interacts with hREST4 to promote neural differentiation of hESCs 
Although we observed a positive correlation between TRF2 and hREST4 expression, it remained 
unclear how this occurs. Since overexpression of TRF2 did not increase REST in hESCs (Fig. 
6D; Fig. S5E) and hREST4 in HEK-293T cells (Fig. S5A), it is unlikely that TRF2 enhances 
hREST4 expression through direct regulation of REST transcription or splicing. Given that 
TRF2 acts as a protein hub and therefore interacts with many proteins [10, 11], it is conceivable 
that TRF2 may affect hREST4 through protein-protein interaction. Indeed, TRF2 co-
immunoprecipitation in NPCs showed that endogenous hREST4 but not REST could be detected 
in TRF2 immunoprecipitates (Fig. 7A). Furthermore, transient expression of myc-tagged REST 
or hREST4 and HA-tagged TRF2 in HEK293T cells showed that HA-TRF2 was only detectable 
in the myc-hREST4 immunoprecipitates but not in myc-REST (Fig. 7B); conversely, only myc-
tagged hREST4 could be detected in the HA-TRF2 immunoprecipitates (Fig. 7C).   
Although hREST4 is largely considered as a truncated REST, the 13 amino acids (AAs) encoded 
by exon N are unique to hREST4 and contain the TRF2 core binding motif [Y/F]xL (Fig. 6C) [9, 
10]. To address whether these 13 AAs are critical for hREST4 binding to TRF2, we generated a 
mutant hREST4 (hREST4m) lacking these 13 AAs (Fig. 6C). When HA-TRF2 with either wild-
type myc-hREST4 or mutant myc-hREST4m were transiently transfected into HEK293T cells, 
only myc-hREST4 was detected in HA-TRF2 immunoprecipitates, indicating that the 13 AAs at 
the C-terminus of hREST4 are essential for the TRF2-hREST4 interaction (Fig. 7D). As such, 
the uniqueness of these residues to hREST4 and their absence in full length REST confer binding 
specificity in favor of hREST4 to TRF2. We also observed that high levels of TRF2 reduced the 
ubiquitination of hREST4 (Fig. 7E), which could prevent its proteasome-mediated degradation. 
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Although the identity of the hREST4-specific E3 ubiquitin ligase remains unknown, hREST4 is 
nonetheless to be regulated by a proteasomal-mediated degradation mechanism (Fig. S5F). 
Therefore, high levels of TRF2 stabilize and increase the resistance of hREST4 to degradation, 
resulting in higher levels of hREST4, which promote the neural differentiation of hESCs. 
 
DISCUSSION 
In this study, we have demonstrated that TRF2 plays a critical role in the neural differentiation of 
hESCs and the maintenance of NPCs, independent of its role in regulating telomere length and 
protecting telomeres. TRF2 protein is dramatically upregulated upon neural differentiation of 
hESCs and maintained at high levels during the extended culture of NPCs. This upregulation 
appears to be specific to hESC neural differentiation as neither the differentiation of hESCs to 
other lineages nor differentiation of mESCs to neural progenitors revealed similar increases. 
These results are consistent with in vivo data, which show that TRF2 is expressed at a much 
higher level in the human brain than in other tissues [14], indicating that TRF2 may have an 
important function within neural tissues. Indeed, in this study we have demonstrated that ectopic 
expression of TRF2 in hESCs promotes neural differentiation, whilst knockdown of TRF2 
impedes neural progenitor generation and maintenance, ultimately hindering the conversion of 
NPCs to neurons and glia. Our results suggest that TRF2 is a vital factor for the differentiation to 
and maintenance of NPCs, which may consequently have important implications on brain 
function. 
In deciphering the molecular mechanisms underlying the role of TRF2 in neural differentiation, 
we discovered that the differential expression of TRF2 during neural differentiation correlates 
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with the expression of hREST4 protein, a truncated REST generated by the alternative splicing 
of exon N from the REST gene. Although three transcripts, N4, N50 and N62, can be generated 
by alternative splicing of exon N at different sites and all lead to premature termination of the 
REST protein, only the latter two produce a truncated REST protein with same additional 13 
AAs at the C-terminus (Fig. S5D), necessary for interaction with TRF2 [16, 39]. Since the N62 
transcript was mainly expressed in neural tissues/cells as rodent REST4 [16], we coined this 
protein as hREST4. Rodent REST4 has been widely reported to counteract the repression of 
REST on target genes, promoting neural gene expression and neurogenesis [35-38] as it lacks the 
C-terminal repression domain of REST and is unable to interact with CoREST [40, 41]. We 
show now that hREST4 is also able to promote the neural differentiation of hESCs, possibly 
through affecting the repression on neural genes by REST. Although overexpression of 
‘hREST4’ in murine neuroblastoma cells was found not to reduce the repression of REST on 
human synapsin promoter-driven luciferase expression [42], this was performed using only a 
single promoter in a tumour cell line, which may not be the case across all cell lines. Moreover, 
we demonstrated that TRF2 interacts with hREST4 to protect hREST4 from ubiquitin-mediated 
degradation by the proteasome, hence positively regulating neural progenitor formation and 
maintenance.  
TRF2 has been reported to be capable of regulating neural differentiation in human embryonic 
carcinoma NTera2 cells by stabilizing REST expression [33]. Here we have taken this study into 
a more physiological context and demonstrated that TRF2 is also involved in regulating neural 
differentiation process of hESCs. However, we show that TRF2 enhances hREST4 expression 
during this process, which counteracts the repression of REST on neural genes to promote neural 
progenitor formation. The discrepancy of the two studies could be attributed to the two different 
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cell types used where TRF2, REST and hREST4 are differentially expressed. We have shown 
that TRF2 and REST are expressed at considerably higher levels in NTera2 cells than in hESCs, 
which may not reflect their physiological levels in normal pluripotent cells. This could affect 
their interaction and function due to the intricacies of protein complex formation. Nonetheless, 
the fact that high-TRF2 expressing NTera2 cells are more readily differentiated into neural 
lineages than hESCs further supports the idea of TRF2 promoting neural differentiation.  
Reducing REST repression on its target genes plays an important role in controlling neural gene 
expression and neural differentiation. During neural differentiation of mESCs, repression of 
REST is alleviated by a considerable reduction of REST protein in which REST undergoes 
proteasomal degradation through β-TrCP-mediated ubiquitination [3]. However, in both H1 and 
H7 hESCs, we observed no such reduction of REST during this differentiation, probably due to 
the expression of HAUSP deubiquitylase and low levels of β-TrCP [25]. Instead, the hESCs 
exhibit a clear upregulation of hREST4 following neural differentiation, which is regulated by an 
increase of TRF2. Therefore, we propose an alternative mechanism that regulates this process. 
High levels of TRF2 stabilize hREST4, enhancing its accumulation, which subsequently 
counteracts the repression of REST on neural target genes, leading to the induction of neural 
differentiation (Fig. 7F). Our findings are further supported by the notion that alternative splice 
variants play a major role in the regulation of gene expression, which is particularly prominent in 
the CNS [43, 44]. Overall, our results suggest that repression of REST on its target genes is 
reduced in the neural differentiation of both human and mouse ESCs but is regulated through 
different mechanisms. The balance of hREST4 and REST is important for human neural 
differentiation and NPC maintenance for which high levels of TRF2 are crucial.  
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In summary, we have identified a novel extra-telomeric function for TRF2, a function that is of 
critical importance to the differentiation and maintenance of human NPCs. These progenitor 
cells are essential to the proper development and function of the CNS which underscores their 
therapeutic value in the potential treatment of neurodegenerative disorders. Given the high 
expression of TRF2 in the human brain, our findings will benefit further exploration of its role in 
normal brain function and aid in the improved procurement of human NPCs for use in future 
regenerative therapies. 
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Figure Legends 
 
Figure 1. Upregulation of TRF2 protein after neural differentiation of hESCs. (A) Expression 
of TRF1 and TRF2 mRNAs by qRT-PCR during the neural differentiation of H1 and H7 hESCs 
and subsequent culture of their progenitors. Passage numbers of post-differentiation are 
indicated. Data are presented as mean ± SD of 6-9 PCRs from three independent experiments. 
(B) Immunoblotting showing TRF1 and TRF2 protein levels during the neural differentiation of 
hESCs. Left panels are representative images; right panels are the densitometric analysis as mean 
± SD of three experiments. ** indicates P <0.005. (C) Immunostaining showing considerably 
higher TRF2 in NPCs but not in hESCs as indicated by Oct4 and Sox1 antibody staining, 
respectively. Scale bar = 50 µm. (D) Higher magnification images of TRF2 staining in hESCs 
and NPCs.  Scale bar = 5 µm. (E) Double staining of TRF2 by TRF2 antibody and telomeres by 
telo-FISH in NPCs. Only a proportion of TRF2 signals show co-localization with telomeres 
(arrowheads). Scale bar = 5 µm. 
 
Figure 2. Comparison of TRF2 expression in hESC-derived NPCs and hESC-derived other cell 
types. (A) Phase-contrast images of hESCs and their derived progenies: NPC, neural progenitor 
cells; FC, fibroblasts; HPC, hepatocyte progenitor cells. (B) Expression of lineage-specific 
marker genes by qRT-PCR in the indicated cells. Data is presented as mean ± SD of 6 RT-PCRs 
from three independent experiments. (C) TRF2 protein expression by immunoblotting in the 
above cells. (D-E) NPCs from early (D) & late (E) neural differentiation were cultured in the 
presence or absence of growth factors (GF) for 14 days and then analyzed by either 
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immunostaining of the cells with indicated antibodies (upper panels) or immunoblotting of their 
cell extracts with TRF2 antibody (lower panels). Scale bar = 50 µm in all microscopic images. 
 
Figure 3. No correlation between TRF2 expression and telomere length or telomerase 
expression in NPCs. (A) Expression of telomerase catalytic subunit hTERT mRNA in hESCs 
and their neural progenitors by qRT-PCR. Data is presented as mean ± SD of three experiments. 
(B) Dynamic changes of telomere length in hESCs and their NPCs by TRF Southern blotting. 
(C) Comparison of telomere length (upper panel, by telomere PNA-FISH) and TRF2 expression 
(lower panel, by immunostaining) in hESCs and their late passage NPCs. Inserts are the same 
images but with a higher magnification. 
 
Figure 4. Induction of neural differentiation in TRF2-ov hESCs. (A) Schematic map of 
transgene expression in a lentiviral vector. CAG, CAG promoter; PuroR, puromycin resistant 
gene; 2A, 2A sequence; TRF2, TRF2 cDNA. (B) Representative phase-contrast images of 
control and TRF2-ov hESCs 4 passages post-selection. Scale bar = 100 µm. (C) TRF2 
overexpression in hESCs increased the expression of neural marker genes but reduced the 
expression of pluripotent genes as detected by qRT-PCR in cells 5 passages after selection. Data 
are presented as mean ± SD of 6 repeats of 2 independent experiments. (D) Immunoblot showing 
indicated protein expression in control and TRF2-ovhESCs. (E) Flow cytometry analysis of Tra-
1-81 and Pax6 in control and TRF2-ov cells (passage 11) shows decreased Tra-1-81 and 
increased Pax6 positive population in TRF2-ov cells. (F-G) Immunostaining with indicated 
antibodies depicting areas of neural differentiation in TRF2-ov hESCs (p5-6). Scale bar = 50 µm. 
(H) Comparison of telomere length in control and TRF2-ov hESCs at two indicated passages by 
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Southern blotting shows that telomere length shortening occurred after 5 passages in TRF2-ov 
hESCs. 
 
Figure 5. Knockdown of TRF2 in hESCs and NPCs hinders neural differentiation and 
impedes the formation of neurons and glia. (A) Decrease of TRF2 expression in TRF2-
knockdown (TRF2-sh) hESCs and NPCs by immunoblotting. (B) Reduction of TRF2 staining in 
TRF2-sh NPCs. Scale bar = 50 µm. (C) Phase-contrast images of control and TRF2-sh hESCs in 
hESC (upper) and neural differentiation (lower) culture conditions. (D-F) Knockdown TRF2 in 
hESCs. (D) Expression of pluripotent genes by qRT-PCR in cells under hESC culture conditions. 
(E) Immunostaining with indicated antibodies in cells after EB differentiation. (F) Expression of 
neural progenitor markers by qRT-PCR after neural differentiation. (G-J) Knockdown TRF2 in 
NPCs. Expression of neural makers by qRT-PCR (G) and immunostaining (H). (I) Phase-
contrast images of NPCs grown in culture with (upper, +GF) or without growth factors (lower,-
GF). (J) NPCs cultured for 2 weeks without growth factors were stained with Tuj1 and GFAP 
antibodies. Error bars represent standard derivation from 6-8 repeats of two independent 
experiments in D, F and G. Scale bar = 50 µm in B, E H & J and 100 µm in C & I. 
 
Figure 6. TRF2 affects NPCs via upregulating hREST4 expression. (A) Immunoblotting of cell 
extracts from H1 and H7 hESCs and their early and late NPCs with indicated antibodies, 
showing upregulation of TRF2 and hREST4 in NPCs. (B) Quantitative analysis of (A) was 
performed by densitometry of the blots and presented as histogram. (C) Schematic map of 
human REST gene, REST/hREST4 transcripts and proteins, and mutated REST4 protein. Open 
and colored boxes represent exons and coding regions, respectively. hREST4-specific amino 
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acids are shown in red. (D-E) Immunoblotting of cell extracts from TRF2-ov hESCs and TRF2-
sh NPCs as well as their corresponding controls with indicated antibodies. Histograms are 
densitometric analysis of the blot shown on left. (F-H) Ectopic expression of hREST4 in TRF2-
sh NPCs as shown by immunoblotting (F) increases expression of neural progenitor markers (G) 
and formation of neurons and astrocytes (H) in compare to TRF2-sh NPCs. Scale bar = 50 µm. 
 
Figure 7. TRF2 interacts with hREST4 to inhibit its ubiquitination. (A) Immunoblot of 
endogenous TRF2 immunoprecipitates or whole cell lysate from NPCs with REST and Rap1 
antibodies. (B-C) HEK293 cells were transiently expressed with HA-TRF2, Myc-REST and 
Myc-hREST4 individually or combined as indicated. Myc (B) or HA (C) immunoprecipitates 
were analyzed by immunoblotting with Myc and HA antibodies. (D) HA immunoprecipitates 
from HEK293 cells co-expressing HA-TRF2 with either myc-hREST4 or myc-hREST4m were 
analyzed by immunoblotting with Myc and HA antibodies. (E) TRF2 inhibits hREST4 
ubiquitination. Myc-hREST4 and HA-ubiquitin (HA-Ub) were transiently expressed in 
HEK293T cells that ectopically express TRF2 or control vectors. Myc immunoprecipitates were 
immunoblotted with indicated antibodies. (F) A schematic model for the role of TRF2, REST 
and hREST4 in regulating neural differentiation of hESCs and functional NPCs. 
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Figure 1. Upregulation of TRF2 protein after neural differentiation of hESCs. (A) Expression of TRF1 and 
TRF2 mRNAs by qRT-PCR during the neural differentiation of H1 and H7 hESCs and subsequent culture of 
their progenitors. Passage numbers of post-differentiation are indicated. Data are presented as mean ± SD 
of 6-9 PCRs from three independent experiments. (B) Immunoblotting showing TRF1 and TRF2 protein levels 
during the neural differentiation of hESCs. Left panels are representative images; right panels are the 
densitometric analysis as mean ± SD of three experiments. ** indicates P <0.005. (C) Immunostaining 
showing considerably higher TRF2 in NPCs but not in hESCs as indicated by Oct4 and Sox1 antibody 
staining, respectively. Scale bar = 50 µm. (D) Higher magnification images of TRF2 staining in hESCs and 
NPCs.  Scale bar = 5 µm. (E) Double staining of TRF2 by TRF2 antibody and telomeres by telo-FISH in NPCs. 
Only a proportion of TRF2 signals show co-localization with telomeres (arrowheads). Scale bar = 5 µm.  
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Figure 2. Comparison of TRF2 expression in hESC-derived NPCs and hESC-derived other cell types. (A) 
Phase-contrast images of hESCs and their derived progenies: NPC, neural progenitor cells; FC, fibroblasts; 
HPC, hepatocyte progenitor cells. (B) Expression of lineage-specific marker genes by qRT-PCR in the 
indicated cells. Data is presented as mean ± SD of 6 RT-PCRs from three independent experiments. (C) 
TRF2 protein expression by immunoblotting in the above cells. (D-E) NPCs from early (D) & late (E) neural 
differentiation were cultured in the presence or absence of growth factors (GF) for 14 days and then 
analyzed by either immunostaining of the cells with indicated antibodies (upper panels) or immunoblotting 
of their cell extracts with TRF2 antibody (lower panels). Scale bar = 50 µm in all microscopic images.  
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Figure 3. No correlation between TRF2 expression and telomere length or telomerase expression in NPCs. 
(A) Expression of telomerase catalytic subunit hTERT mRNA in hESCs and their neural progenitors by qRT-
PCR. Data is presented as mean ± SD of three experiments. (B) Dynamic changes of telomere length in 
hESCs and their NPCs by TRF Southern blotting. (C) Comparison of telomere length (upper panel, by 
telomere PNA-FISH) and TRF2 expression (lower panel, by immunostaining) in hESCs and their late passage 
NPCs. Inserts are the same images but with a higher magnification.  
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Figure 4. Induction of neural differentiation in TRF2-ov hESCs. (A) Schematic map of transgene expression 
in a lentiviral vector. CAG, CAG promoter; PuroR, puromycin resistant gene; 2A, 2A sequence; TRF2, TRF2 
cDNA. (B) Representative phase-contrast images of control and TRF2-ov hESCs 4 passages post-selection. 
Scale bar = 100 µm. (C) TRF2 overexpression in hESCs increased the expression of neural marker genes but 
reduced the expression of pluripotent genes as detected by qRT-PCR in cells 5 passages after selection. Data 
are presented as mean ± SD of 6 repeats of 2 independent experiments. (D) Immunoblot showing indicated 
protein expression in control and TRF2-ovhESCs. (E) Flow cytometry analysis of Tra-1-81 and Pax6 in 
control and TRF2-ov cells (passage 11) shows decreased Tra-1-81 and increased Pax6 positive population in 
TRF2-ov cells. (F-G) Immunostaining with indicated antibodies depicting areas of neural differentiation in 
TRF2-ov hESCs (p5-6). Scale bar = 50 µm. (H) Comparison of telomere length in control and TRF2-ov 
hESCs at two indicated passages by Southern blotting shows that telomere length shortening occurred after 
5 passages in TRF2-ov hESCs.  
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Figure 5. Knockdown of TRF2 in hESCs and NPCs hinders neural differentiation and impedes the formation of 
neurons and glia. (A) Decrease of TRF2 expression in TRF2-knockdown (TRF2-sh) hESCs and NPCs by 
immunoblotting. (B) Reduction of TRF2 staining in TRF2-sh NPCs. Scale bar = 50 µm. (C) Phase-contrast 
images of control and TRF2-sh hESCs in hESC (upper) and neural differentiation (lower) culture conditions. 
(D-F) Knockdown TRF2 in hESCs. (D) Expression of pluripotent genes by qRT-PCR in cells under hESC 
culture conditions. (E) Immunostaining with indicated antibodies in cells after EB differentiation. (F) 
Expression of neural progenitor markers by qRT-PCR after neural differentiation. (G-J) Knockdown TRF2 in 
NPCs. Expression of neural makers by qRT-PCR (G) and immunostaining (H). (I) Phase-contrast images of 
NPCs grown in culture with (upper, +GF) or without growth factors (lower,-GF). (J) NPCs cultured for 2 
weeks without growth factors were stained with Tuj1 and GFAP antibodies. Error bars represent standard 
derivation from 6-8 repeats of two independent experiments in D, F and G. Scale bar = 50 µm in B, E H & J 
and 100 µm in C & I.  
129x99mm (300 x 300 DPI)  
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Figure 6. TRF2 affects NPCs via upregulating hREST4 expression. (A) Immunoblotting of cell extracts from 
H1 and H7 hESCs and their early and late NPCs with indicated antibodies, showing upregulation of TRF2 and 
hREST4 in NPCs. (B) Quantitative analysis of (A) was performed by densitometry of the blots and presented 
as histogram. (C) Schematic map of human REST gene, REST/hREST4 transcripts and proteins, and mutated 
REST4 protein. Open and colored boxes represent exons and coding regions, respectively. hREST4-specific 
amino acids are shown in red. (D-E) Immunoblotting of cell extracts from TRF2-ov hESCs and TRF2-sh NPCs 
as well as their corresponding controls with indicated antibodies. Histograms are densitometric analysis of 
the blot shown on left. (F-H) Ectopic expression of hREST4 in TRF2-sh NPCs as shown by immunoblotting (F) 
increases expression of neural progenitor markers (G) and formation of neurons and astrocytes (H) in 
compare to TRF2-sh NPCs. Scale bar = 50 µm.  
162x151mm (300 x 300 DPI)  
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Figure 7. TRF2 interacts with hREST4 to inhibit its ubiquitination. (A) Immunoblot of endogenous TRF2 
immunoprecipitates or whole cell lysate from NPCs with REST and Rap1 antibodies. (B-C) HEK293 cells were 
transiently expressed with HA-TRF2, Myc-REST and Myc-hREST4 individually or combined as indicated. Myc 
(B) or HA (C) immunoprecipitates were analyzed by immunoblotting with Myc and HA antibodies. (D) HA 
immunoprecipitates from HEK293 cells co-expressing HA-TRF2 with either myc-hREST4 or myc-hREST4m 
were analyzed by immunoblotting with Myc and HA antibodies. (E) TRF2 inhibits hREST4 ubiquitination. Myc-
hREST4 and HA-ubiquitin (HA-Ub) were transiently expressed in HEK293T cells that ectopically express TRF2 
or control vectors. Myc immunoprecipitates were immunoblotted with indicated antibodies. (F) A schematic 
model for the role of TRF2, REST and hREST4 in regulating neural differentiation of hESCs and functional 
NPCs.  
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Figure S1. TRF2 expression during neural differentiation of human and mouse ESCs. (A) Immunoblotting 
with short (S) and long (L) exposure showing that TRF2 is expressed in hESCs but at a much lower level and 
upregulated after neural differentiation. (B) Comparison of TRF2 expression in mouse and human pluripotent 
stem cells and NPCs by immunoblotting showing that TRF2 expression is lower in mouse cells and was not 
upregulated after neural differentiation. hESC and mESC human  and mouse embryonic stem cell, 
respectively; hNPC and mNPC human and mouse neural progenitor cell, respectively; mEpiSC, mouse 
epiblast stem cell.  
40x19mm (300 x 300 DPI)  
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Figure S2. TRF2 expression in EB and other cell lines. (A) H1 hESCs were differentiated through embryoid 
body (EB) formation for 14 days and stained with TRF2 and indicated antibodies. TRF2 was stained positively 
in Sox2 positive cells but not in Oct4 or HNF4α positive cells, showing its specificity in neural progenitors. 
(B) Immunoblotting of TRF2 in hESC-derived neural progenitors (NPC), HeLa tumor cell line, primary Hs27 
and telomerase-immortalized BJ fibroblasts.  
112x128mm (300 x 300 DPI)  
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Figure S3. Effect of ectopic expression of TRF2 in hESCs and their neural differentiation. (A) Representative 
phase-contrast images of p18 control and TRF2-ov hESCs, showing clear neural differentiation. Scale bar = 
100 µm. (B) TRF2-ov hESCs (p2) and controls were subjected into neural differentiation for 12 days. Cell 
extracts were analyzed by immunoblotting and showed accelerated downregulation of Oct4 proteins. (C) 
Immunostaining with Oct4 and Nestin antibodies in cells of (B) showing clear downregulation of Oct4 and 
upregulation of Nestin.  Scale bar = 50 µm.  
84x70mm (300 x 300 DPI)  
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Figure S4. Effect of TRF2-sh in hESCs and NPCs. (A) Control and TRF2-sh hESCs were differentiated into 
neurons and stained with anti-Tuj1 antibody. (B) Growth curves of control and TRF2-sh NPCs in NPC 
cultures. (C) Representative images of phospho-H3 antibody staining in control and TRF2-sh NPCs. 
Quantitative analysis shows reduced phosphor-H3 staining in TRF2-sh cells. (D) Immunostaining with active 
caspase-3 antibody shows no increase of apoptosis detected in TRF2-sh cells. (E) Measurement of Telomere 
lengths by Southern blotting in control and TRF2-sh hESCs 10 passages after selection. (F) Telomere lengths 
in control, TRF2-ov and TRF2-sh NPCs. (G) Representative images of metaphase spread show no 
chromosome fusion in TRF2-sh NPCs (p5). Scale bar = 50 µm in A, C & D.  
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Figure S5. REST and hREST4 expression. (A) Immunoblotting analyses show that TRF2 overexpression in 
HEK293T (TRF2-ov) cells has no effect on REST and REST4 expression levels. (B) TRF2, REST and Oct4 
expression in hESCs, NPCs and NTera2 cells by immunoblotting. Both TRF2 and REST exhibit different 
expression pattern in hESCs and NTera2 cells. (C) Immunoblotting with the REST antibody showing REST 
and hREST4 proteins in HEK293T cells ectopically expressing these two proteins. (D) Partial mRNA and 
protein sequences of human and mouse alternative splicing variants of exon N. mRNA sequences of exon N 
are indicated in red while mRNA sequences of exon IV and V are in black and black with underline, 
respectively. (E) qRT-PCR with isoform-specific primers show that TRF2 overexpression also increases 
hREST4 mRNA levels but not REST. Data are presented as mean ± SD from three independent experiments. 
(F) hREST4 protein can be degraded by a proteasome-dependent mechanism. hESC-derived NPCs were 
treated with either proteasome inhibitor MG132 or protein translation inhibitor cycloheximide (CHX) for 6 
hours. The cell extracts were then analyzed by immunoblotting for hREST4 expression levels.  
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Figure S6. Ectopic expression of hREST4 in hESCs hinders their self-renewal and promotes neural 
differentiation. (A) Phase-contrast images of control (left) and hREST4 overexpressing (right) hESCs, 3 
passages post-selection in hESC culture conditions (upper) and 19 days after neural differentiation (lower). 
(B) Gene expression analysis by qRT-PCR. Data are presented as mean ± SD of at least 8 repeats of 2 
independent experiments. (C) Immunoblotting showing downregulation and upregulation of Oct4 and Pax6, 
respectively following hREST4 overexpression. No effect is detected on REST levels. (D-E) Immunostaining 
of hREST4-ov and control cells with indicated antibodies in hESC (D) and 13 days after neural differentiation 
(E). Scale bars represent 100 µm in A and 50 µm in D & E.  
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Table S1 . List of antibodies for immunoblotting and immunocytochemistry 
Antibody Type Company Catalogue 
number 
IF 
Dilution 
WB 
Dilution 
β-Actin 
mouse 
monoclonal 
Sigma-
Aldrich 
A5441 1:5000 1:5000  
β-tubulin III (Tuj1) 
mouse 
monoclonal 
Sigma-
Aldrich 
T8660 1:1000 - 
Caspase 3 
rabbit polyclonal Cell 
Signalling 
9662 1:1000 - 
GFAP  
rabbit antiserum DAKO Z0334 1:500 - 
HA 
mouse 
monoclonal 
Sigma-
Aldrich 
H3663 - 1:1000 
HA 
rabbit polyclonal Sigma-
Aldrich 
H6908 - 1:1000 
HNF4a (H-171) 
rabbit polyclonal Santa 
Cruz 
sc-8987 1:50 1:200  
Myc 
mouse 
monoclonal 
Santa 
Cruz 
SC-40 - 1:1000 
Nestin 
mouse 
monoclonal 
Chemicon MAB 5326 1:200 1:500 
Oct4 
rabbit polyclonal abcam ab19857 1:200 1:500 
Oct4 
mouse 
monoclonal 
Santa 
Cruz 
sc-5279 1:250 1:1000 
Pax-6 
mouse 
monoclonal 
Hybridoma Bank 1:50 - 
Phospho-H3 (Ser10) 
rabbit polyclonal Millipore 05-806 1:200 - 
RAP1 
Rabbit polyclonal Bethyl labs A300-306A 1:1000 1:1000 
REST 
Rabbit 
monoclonal 
Epitomics 2417-1 - 1:2000 
Sox1 
rabbit polyclonal Abcam  ab87775 1:500 1:1000 
Sox2 
rabbit polyclonal Abcam ab97959 1:500 1:1000 
Tra-1-81 
mouse 
monoclonal 
Santa 
Cruz 
sc-21706 1:50-
1:500 
1:100-
1:1000 
TRF1 
mouse 
monoclonal 
Millipore 04-638 1:100 1:1000 
TRF2 
mouse 
monoclonal 
Millipore 05-521 1:500 1:500 
TRF2 (H-300) 
rabbit polyclonal Santa 
Cruz 
sc-9143 1:30 1:200 
γ-H2A.X (S139) 
rabbit polyclonal Upstate 07-164 - 1:500 
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 Table S2. Primers for qRT-PCR 
Gene name  Forward primer 5'-3' Reverse primer 5'-3' 
GAPDH TCTGCTCCTCCTGTTCGACA AAAAGCAGCCCTGGTGACC 
GAPDH TCTGCTCCTCCTGTTCGACA AAAAGCAGCCCTGGTGACC 
Gata6 ACTTGAGCTCGCTGTTCTCG CAGCAAAAATACTTCCCCCA 
GFAP CACCACGATGTTCCTCTTGA GTGCAGACCTTCTCCAACCT 
HPRT TCCTTGGTCAGGCAGTATAATCC GTCAAGGGCATATCCTACAACAAA 
hREST4 CATACACAACAGTGAGCGAG CCAAATGGTATCCATACCCC 
hTERT TCAACCGCGGCTTCAAG TCCAGAAACAGGCTGTGACACT 
Mash1 GGAGCTTCTCGACTTCACCA CTAAAGATGCAGGTTGTGCG 
Nanog TGATTTGTGGGCCTGAAGAAAA GAGGCATCTCAGCAGAAGACA 
nSR100 GAACTGGGTGCCACCAGAGG CCCCTGGAGGAAGGTGGTGG 
Oct4 TCGAGAACCGAGTGAGAGGC CACACTCGGACCACATCCTTC 
REST TGTCCTTACTCAAGTTCTCAGAAGA  GAGGCCACATAACTGCACTG 
Snap25 CTGTCTTTCCTTCCCTCCCT GGGTCAGTGACGGGTTTG 
Sox1 AACACTTGAAGCCCAGATGGA GCAGGCTGAATTCGGTTCTC  
Sox2 CACACTGCCCCTCTCACACAT CATTTCCCTCGTTTTTCTTTGAA 
Sox17 GGCGCAGCAGAATCCAGA  CCACGACTTGCCCAGCAT 
TRF1 AATTTGTTGAACCCTGCCAC ACAGGGTTGAGGTCAGCCTA 
TRF2 CCGTTCTCAACCAACCCCTC GCTGCCTGAACTTGAAACAGT 
Tuj1 AGTGTGAAAACTGCGACTGC ACGACGCTGAAGGTGTTCAT 
 
 
Page 45 of 45
